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Abstract Osteoarthritis is a degenerative joint disease
mostly occurring in the knee and commonly seen in middle-
aged and elderly adults. Intra-articular injection of hyaluronic
acid has been widely used for treatment of knee osteoarthritis.
The aim of this study was to evaluate the efficacy of intra-
articular injection of a novel highly cross-linked hyaluronic
acid, alone or in combination with ropivacaine hydrochloride
and triamcinolone acetonide, on knee articular cartilage in a
rabbit model of collagenase-induced knee osteoarthritis. After
induction of experimental osteoarthritis by intra-articular
injection of collagenase, adult New Zealand white rabbits
(n = 12) were divided into 3 groups. Group 1 (control group)
received 0.3 ml phosphate buffered saline into the right knee
joint. Group 2 received 0.3 ml cross-linked hyaluronic acid
(33 mg/ml) into the right knee joint. Group 3 received a
mixture of 0.15 ml cross-linked hyaluronic acid (33 mg/ml),
0.05 ml ropivacaine hydrochloride 1 % and 0.1 ml triam-
cinolone acetonide (10 mg/ml) into the right knee joint. Intra-
articular injections were given 4 weeks after first collagenase
injection and were administered once a week for 3 weeks.
Gross pathology and histological evaluation of rabbits’ knee
joints were performed after 16 weeks following initial colla-
genase injection. Histological analysis of sections of right
knee joints at lesion sites showed a significant decrease in
Mankin’s score in groups treated with hyaluronic acid alone or
in combination with ropivacaine hydrochloride and triam-
cinolone acetonide versus control group (p \ 0.05 and
p \ 0.01 respectively). This evidence was consistent with
strong articular degenerative changes in control right knee
joints (grade III osteoarthritis), while the treated groups
revealed less severe articular degenerative changes (grade II
osteoarthritis). The present results show that cross-linked
hyaluronic acid, alone or in combination with ropivacaine
hydrochloride and triamcinolone acetonide, produces a sig-
nificant improvement in knee articular cartilage degeneration
in a rabbit model of collagenase-induced osteoarthritis.
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Introduction
Osteoarthritis (OA) is a degenerative joint disease mostly
occurring in the knee and commonly seen in middle-aged
and elderly adults. Knee OA is one of the major causes of
pain and disability. OA-related pain and disability signifi-
cantly affect the patients’ quality of life. Non-surgical
procedures to manage OA include weight loss, exercise,
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activity modification, assistive devices, non-steroidal anti-
inflammatory drugs (NSAIDs), analgesics, and intra-artic-
ular (IA) hyaluronic acid (HA) injection (Hochberg et al.
1995; Iannitti et al. 2011). Current symptom management
is directed to relieve pain regaining function (Elron-Gross
et al. 2008). However, treatments available are limited and
outcomes are poor due to the high incidence of side effects.
For example, oral administration of NSAID tablets relieves
inflammation and pain, but may cause serious gastroin-
testinal adverse effects. IA drug delivery can be useful in
order to treat joint inflammation and pain. IA HA injection
is a well-documented treatment for knee OA and is
approved worldwide (Jiang et al. 2010; Gigante and
Callegari 2011). HA is a glycosaminoglycan responsible
for the maintenance of healthy synovial fluid viscoelastic-
ity (Bingo¨l et al. 2010). These peculiar properties of HA
guarantee an extremely low-friction environment within
the joints. Arthropathies lead to a reduction in synovial
fluid viscoelasticity due to a decrease in concentration and/
or HA molecular weight (Altmann et al. 1980). A high
synovial fluid viscoelasticity is necessary for lubrication,
shock absorption and load-bearing and is required to pre-
vent mechanical trauma and articular cartilage wear during
load-bearing movement (Schurz 1996). IA HA injection
aims at decreasing OA-related pain and improving joint
function by restoring synovial fluid physiological proper-
ties (Balazs and Gibbs 1970). There has been a consider-
able controversy about whether HA therapy has structure-
modifying properties. IA HA administration produces well
documented structure-modifying effects, as observed in
several animal species. For instance, Wiig et al. (1990)
reported that administration of a single injection of Healon,
immediately after anterior cruciate ligament transaction in
rabbits, resulted in significantly decreased inflammation,
increased collagen synthesis and angiogenesis and
enhanced tissue repair if compared to a single injection of
saline solution (Wiig et al. 1990). Furthermore, Armstrong
et al. (1994) and Kikuchi et al. (1996) investigated the
structure-modifying effects of HA using a sheep and rabbit
model of meniscectomy (Armstrong et al. 1994; Kikuchi
et al. 1996). IA injection of HA, after partial meniscectomy
in these species, resulted in significantly inhibited cartilage
degeneration (Armstrong et al. 1994; Kikuchi et al. 1996).
A further study by Marshall et al. (2000) evaluated Synvisc
in a dog anterior cruciate ligament transaction model
(Marshall et al. 2000). Gross morphological and histolog-
ical damage within joints that received injections were
significantly milder if compared to control joints (Marshall
et al. 2000). The positive effect of IA HA in patients
affected by knee OA has also been observed in many
clinical studies. For example, Leardini et al. (1991) studied
40 patients affected by this condition and reported that the
IA injection of HA was as effective as cortisone, and the
side effects of both treatments were of short duration and
negligible. Another study compared HA and cortisone
administration in 63 patients with knee OA once a week for
5 weeks (Jones et al. 1995). This study showed that pain
was less severe in the HA group if compared with the
cortisone group after a 6-month follow up. Pietrogrande
and coworkers compared the activity and tolerability of HA
and cortisone administration in patients affected by knee
OA (Pietrogrande et al. 1991). HA was administered once a
week for 5 weeks and cortisone once a week for 3 weeks.
They observed that the latter had a more rapid action
(Pietrogrande et al. 1991). Song and Chang reported that
IA injections with either HA or triamcinolone acetonide are
effective for treatment of knee OA with no significant
differences in the outcome (Song and Chang 2004). On the
other hand, a study in the rabbit showed that, in the long
term, HA was more effective than cortisone as far as
degenerative knee OA healing was concerned (Karakok
et al. 2001). Furthermore, a combination of cortisone and
HA was the most effective in treatment of cartilage
degeneration in a rabbit model of knee OA, if compared to
HA alone (Karakurum et al. 2003). IA HA also appears to
have a long-lasting effect in relieving knee OA-related pain
if compared to IA corticosteroids. This was pointed out in a
meta-analysis by Bannuru et al. (2009) where, from base-
line to week 4, IA corticosteroids were relatively more
effective for pain relief if compared to IA HA but, by week
4, the 2 approaches had equal efficacy and, beyond week 8,
HA had greater efficacy. This trend is of particular
importance for clinicians using IA HA for treatment of
knee OA.
Recently, local drug delivery has been widely used for
treatment of OA. Drug delivery strategies may reduce local
joint inflammation and joint destruction, offering pain
relief, and restoring the patient’s activity levels and joint
function (Allen et al. 2010). One of the most important
advantages of IA drug administration is that it can achieve
a targeted delivery of the drug to affected tissues allowing
local treatment and minimizing side effects typical of
systemically administered drugs (Edwards et al. 2007). In
this context micro- and nanocarrier-mediated drug delivery
systems, including polymeric particles and hydrogel, are
well-established as methods for sustained release of drugs
into the IA space (Zhang and Huang 2012). Drug delivery
systems could prolong drug retention time, reduce the drug
clearance into the joint cavity, and increase the patient’s
compliance as well as the therapeutic effect of pharma-
ceutical agents. IA HA injection, alone or in combination
with other drugs, is also widely used in the clinic with a
frequency and dosage calculated on the basis of the disease
pathophysiology (Iannitti et al. 2011). The previously
described studies show that the scientific literature has
widely reported on IA HA/cortisone injection for treatment
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of knee OA, sometimes with controversial results. How-
ever, while in many animal studies the efficacy of non-
cross-linked HA solution alone or combined with other
drugs has been analyzed, evidence of the efficacy of cross-
linked HA gel combined with other pharmaceutical prod-
ucts is still lacking. The hydrogel form is characterized by
cross-linked HA, which allows a longer permanence within
the body, and it is also characterized by greater viscoelastic
properties if compared with the non-cross-linked form of
HA (Oh et al. 2008; Shimojo et al. 2010).
Aim
The aim of the present study was to evaluate the efficacy of
IA injection of a novel cross-linked HA, alone or in com-
bination with ropivacaine hydrochloride and triamcinolone




Twelve female New Zealand white rabbits (age =
12 weeks; weight: 4080–5320 g) were used in this study.
The animals were kept at a temperature of 21–23 C and a
relative humidity of 40–60 %. The animals were allowed
free access to water and they were fed on a rabbit com-
mercial diet. Animal experiments were performed in
accordance with document DIN EN ISO 10993-2 and
according to Germany Animal Welfare Act (Lorz 1987).
Preparation of collagenase solution
Collagenase type II from Clostridium histolyticum (Sigma-
Aldrich, Germany) was dissolved in a sterile phosphate
buffered saline (PBS; Sigma-Aldrich, Germany) solution
(400 U/ml, pH 7.4) and filtered with a 0.22 lm membrane.
Animal model of knee osteoarthritis
Animals were anesthetized with a subcutaneous injection
of Ketamin (0.15 ml/kg Ketamin 10 %, Ceva Tiergesund-
heit GmbH, Du¨sseldorf, Germany) and Medetomidin
(0.1 ml/kg Domitor, Pfizer GmbH, Karlsruhe, Germany).
Rabbit knee joints were shaved and sterilized, and 0.1 ml
collagenase solution was slowly injected into the right knee
joint cavity. The same collagenase injection procedure
was performed 3 days after the first injection to develop
experimental OA according to Kikuchi et al. (1998).
Cross-linked hyaluronic acid
Variofill (33 mg/ml, Adoderm, Langenfeld, Germany) is
a novel divinyl sulfone cross-linked HA engineered to form
a highly cross-linked gel with high viscoelastic properties.
Pharmacological treatment
Animals were divided into 3 groups: (1) 4 rabbits were
used as control group and received 3 injections (day 0, 7,
14) of 0.3 ml PBS into the right knee joint; (2) 4 rabbits
received 3 injections (day 0, 7, 14) of 0.3 ml HA (Vario-
fill; 33 mg/ml) into the right knee joint; (3) 4 rabbits
received 3 injections (day 0, 7, 14) of 0.15 ml HA
(Variofill; 33 mg/ml) plus 0.05 ml ropivacaine hydro-
chloride 1 % (Naropin, AstraZeneca, Wedel, Germany)
plus 0.1 ml triamcinolone acetonide (Valon A10, Der-
mapharm AG, Gru¨nwald, Germany; 10 mg/ml) [mixed
before the injection] into the right knee joint.
Preparation of hyaluronic acid plus ropivacaine
hydrochloride and triamcinolone acetonide mixture
In order to create a mixture of ropivacaine hydrochloride,
triamcinolone acetonide and HA, a 1-ml syringe, containing
0.05 ml of ropivacaine hydrochloride 1 % plus 0.1 ml of tri-
amcinolone acetonide (10 mg/ml), was attached to a syringe
containing 0.15 ml of HA (33 mg/ml) through a Rapid Fill
Connector Luer Lock-to-Luer Lock (Baxa, Englewood, CO).
A continuous push-pull action between syringes was per-
formed in order to create a homogeneous mixture (optimal
results require 20 ‘‘passes’’ between syringes).
Gross pathological observation and histological
evaluation
After 16 weeks from the initial collagenase injection, rabbits
were sacrificed using intravenous injection of ketamine (0.15
ml/kg) followed by 0.3 ml/kg intravenous injection of T61
(Intervet Deutschland GmbH, Unterschleißheim, Germany)
for gross pathological observation and histological evaluation.
Rabbits’ knee joints were dissected after euthanasia. Knee
joint tissue was fixed in 10 % neutral-buffered formalin,
decalcified in EDTA for 2 weeks and 3 lm sections of the
central portion of the knee joint were stained with Hematox-
ylin and Eosin (HE) and Safranin-Orange-fast green (Safra-
nin-O) stainings. Safranin-O staining was used for the
evaluation of degenerative cartilage lesions. Histological
samples were graded using a modified Mankin’s score (0–2:
normal; 3–5: OA grade I; 6–7: OA grade II; 8–10: OA grade
III; 11–14: OA grade IV) to evaluate structure, fissures, clefts,
cells, vascularity and saturation of articular cartilage (Kuroki
J Mol Hist (2013) 44:191–201 193
123
et al. 2004). The maximum score can be achieved when facing
heavily disintegrated and degenerated cartilage.
Statistical analysis
Mankin’s score data were first checked for normality by
means of the Anderson–Darling test using Minitab, v15.
Statistical analysis was performed using GraphPad Prism 5
software. A one-way ANOVA, followed by Bonferroni post
hoc test, was used to compare treatment groups. A value of
p \ 0.05 was considered significant. Data are presented as the
mean ± Standard Error of the Mean (SEM).
Results
Gross pathological analysis
No changes typical of degeneration were observed in the left
joint of treatment and control group animals. Left knee joint
articular cartilage was characterized by a smooth, polished and
regular surface in treatment and control group animals. Artic-
ular cartilage in right knee joint presented with a matt, unpol-
ished and irregular surface (Fig. 1A, B, C). In both treatment
groups, cartilage lesions, associated with OA, were clearly
seen, but the severity was milder than in the control group.
Here, in the marginal zone of trochlea ossis femoris, condylus
lateralis femoris and condylus medialis femoris, osteophyte-
like structures and different grooves were observed.
Histopathological findings
Group 1
In the right knee joint, all animals revealed superficial fibril-
lation of articular cartilage, minimal chondrocyte clustering
and fibrosis in the superficial zone, multifocal extension of
matrix cracks into the mid zone to form vertical fissures
(clefts), destroyed tidemark structures and proliferation of
(A) (B)
(C)
Fig. 1 A Right knee joint of control group rabbit: matt, unpolished
and irregular articular surface with osteophyte-like structure (arrow)
at the marginal zone; B Right knee joint of HA group rabbit: matt,
unpolished and irregular articular surface with osteophyte-like
structure (arrow), different grooves (arrowhead) and newly white
fibrocartilaginous or cartilage-like tissue (stars) on the marginal zone;
C Right knee joint of HA plus ropivacaine hydrochloride and
triamcinolone acetonide group rabbit: matt, unpolished and irregular
articular surface with osteophyte-like structure (arrow), different
grooves (arrowheads) and newly white fibrocartilaginous or cartilage-
like tissue (stars) on the articular surface
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fibrous tissue including active fibroblasts with prominent
nuclei and abundant cytoplasm present at the margin of the
trochlea ossis femoris, condylus lateralis femoris, condylus
medialis femoris and tibial plateau (Fig. 2A, B, C). Addi-
tionally, some adjacent trabeculae, along the junction between
damaged cartilage and subchondral bone, were lined by
osteoblasts present in a rabbit. Multifocal extensive erosion of
superficial zone of condylus femoris was observed in two
animals. The hyaline cartilage showed moderate reduction in
matrix coloration, which was more extensive in superficial
and cracked areas, as assessed by Safranin-O staining (Figs. 3,
4). The right knee synovium showed moderate hypertrophy/
thickening of synovial lining cell layers, multiple finger-like
projections, villi formation and moderate hypertrophy of
subsynovial tissue with few inflammatory infiltrates
and granulation tissue formation including multiple angio-
genesis. Mankin0s score in the control group was 10 ± 0.4
points, which corresponds to grade III OA.
Group 2
In 3 rabbits, articular cartilage of the right knee joint
contained multiple chondrocytes and disoriented chon-
drocytes became more prominent. The right knee syno-
vium revealed moderate hypertrophy (thickening) of
synovial lining cell layers punctuated by oligofocal pieces
of basophilic foreign material, multiple finger-like pro-
jections, villi formation, and moderate hypertrophy of
subsynovial tissue with few inflammatory infiltrates and
granulation tissue formation including multiple angio-
genesis (Figs. 5A, B, E, 6). A rabbit died in the initial
phase of the study and was excluded from the modified
Mankin’s score evaluation. Mankin0s score in the HA
treated group was 7.3 ± 0.6 points, which corresponds to
grade II OA. Therefore a significant decrease in Mankin’s




Fig. 2 A Photomicrograph of sagittal section of condylus femoris of
the right knee joint of control group rabbit showing focal erosion
including fibrillation and multifocal vertical fissures extending into
the deep zone of articular cartilage. HE staining; B Higher magni-
fication of panel A showing articular cartilage erosion, tidemark
destruction (star) and chondrocyte degeneration (arrows). HE stain-
ing; C Transverse section of trochlea ossis femoris of the right knee
joint of control group rabbit showing focal erosion including
fibrillation, superficial peeling and chondrocyte degeneration (arrow)
of articular cartilage. HE staining
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Fig. 3 Articular surface of the right knee joint of control group rabbit
showing fibrocartilage tissue (arrows) covering injured articular
surface with moderate lack of Safranin-O staining in superficial zone
(open star) and irregular staining distribution (depletion of proteo-
glycans; star) in middle and deep zones. Safranin-O staining
Fig. 4 Articular surface of the right knee joint of control group rabbit
showing severe erosion extended to the deep zone with moderate lack
of Safranin-O staining (arrows) and irregular staining distribution
(depletion of proteoglycans) in middle and deep zones of the erosion
area. Safranin-O staining





Fig. 5 A Photomicrograph of transverse section of trochlea ossis
femoris of the right knee joint of HA group rabbit showing
fibrocartilage tissue covering injured articular surface (arrowheads)
and multiple angiogenesis (arrows) of articular cartilage. HE staining;
B Higher magnification of panel A showing fibrocartilage tissue
covering injured articular surface (arrowheads), multiple angiogen-
esis (arrows) and tidemark destruction (star) of articular cartilage. HE
staining; C Sagittal section of condylus femoris of the right knee joint
of HA plus ropivacaine hydrochloride and triamcinolone acetonide
group rabbit showing focal erosion of articular cartilage with
chondrocyte hyperplasia and new cartilage tissue formation. HE
staining; D Higher magnification of panel C showing focal erosion of
articular cartilage with chondrocyte hyperplasia and new cartilage
tissue formation. HE staining; E Synovium of the right knee joint of
HA group rabbit showing hypertrophy (thickening) of synovial lining
cell layers, oligofocal pieces of basophilic foreign material sur-
rounded by granulation tissue including foreign-body giant cells,
lymphocytes and fibrosis, hypertrophy of subsynovial tissue with few
inflammatory infiltrates and multiple angiogenesis. HE staining
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Group 3
Changes in articular cartilage and synovium, including
modified Mankin’s score evaluation of the two rabbits’
right knee joints, were improved if compared to group 1,
(Figs. 5C, D, 7, 8). Two rabbits died in the initial phase of
the study and were therefore excluded from the modified
Mankin’s score evaluation. Mankin0s score in the HA plus
Fig. 6 Articular surface of the right knee joint of HA group rabbit showing fibrocartilage tissue (star) covering injured articular surface with
severe lack of Safranin-O staining in hyaline cartilage matrix. Safranin-O staining
Fig. 7 Articular surface of the right knee joint of HA plus
ropivacaine hydrochloride and triamcinolone acetonide group rabbit
showing focal erosion of articular cartilage and chondrocyte
proliferation (arrows) with severe lack of Safranin-O staining in
new cartilage formation and hyaline cartilage matrix. Safranin-O
staining
198 J Mol Hist (2013) 44:191–201
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ropivacaine hydrochloride plus triamcinolone acetonide
group was 6 points, which corresponds to grade II OA.
Therefore, a significant decrease in Mankin’s score was
observed in this group versus group 1 (p \ 0.01). No sig-
nificant difference in Mankin’s score was observed when
comparing treatment with HA alone versus HA plus ropi-
vacaine hydrochloride plus triamcinolone acetonide.
Discussion
The present study outlines the efficacy of a high visco-
elastic divinyl sulfone cross-linked HA in a rabbit model of
collagenase-induced knee OA. The rationale of using such
a densely coating compound in the knee joint is to relieve
the painful periosteal friction during the movement, and to
help fibroblastic reaction to replace the fragmented carti-
lage, lubricating the synovial space and eventually pro-
moting chondrocyte differentiation. In our study the mix of
HA plus ropivacaine hydrochloride plus triamcinolone
acetonide has been compared with HA alone because, on
the basis of our long-standing clinical experience, espe-
cially in severely inflamed knees presenting synovial
effusion, immediate pain relief, due to local anesthetic and
anti-inflammatory steroid injection helps recover the joint
function soon after infiltration. In our clinical experience,
the addiction of highly cross-linked HA is helpful to
counteract inflammation and take control of further carti-
lage breakdown in the short- to medium-term follow up.
Under a clinical perspective, an instant physical mix of
triamcinolone acetonide and HA, immediately before IA
injection and contemporary injection of ropivacaine
hydrochloride or other suitable local anesthetics, may give
a better functional and morphological restoration.
In the present experimental study, however, no substantial
advantage has been achieved respect to HA alone. This result
is not in agreement with previous findings from Karakurum
et al. (2003) where a combination of HA and cortisone resulted
more effective in treating experimental OA-related cartilage
degeneration if compared to HA alone. An explanation for
these results may be the difference in the animal model used
by Karakurum and colleagues, i.e. a model created by resec-
tion of the cruciate ligament. Furthermore, they used a non-
cross-linked HA and a higher dose of cortisone (15 mg/ml).
In summary, even if the spontaneous arthritic knee
pathogenesis in humans is quite different from the rabbit’s
factitious knee, the present study emphasizes the inde-
pendent role of densely cross-linked glycosaminoglycan in
counteracting the degenerative process, supporting, at least
partially, the functional homeostasis due to its lubricating
effect. However, our study presents a limitation consisting
in the limited number of animals used.
Fig. 8 Transverse section of trochlea ossis femoris of the right knee
joint of HA plus ropivacaine hydrochloride and triamcinolone
acetonide group rabbit showing multiple angiogenesis (arrows) in
the newly formed fibrocartilage tissue with severe lack of Safranin-O
staining in articular cartilage matrix (arrowheads). Safranin-O
staining
J Mol Hist (2013) 44:191–201 199
123
Conclusions
In the present study histopathological findings from the con-
trol group showed that IA administration of collagenase
induced osteoarthritic changes including degradation of
articular cartilage, synovial inflammation, tidemark destruc-
tion, remodelling of subchondral bone structure, osteophyte-
like structure formation and excavation in the knee joint. In
treated animals, some degenerative changes included super-
ficial fibrillation of articular cartilage, vertical fissures
extending into the deep zones and chondrocyte degeneration.
These changes give evidence on the reparative process of
articular cartilage. This process included complex chondrons,
fibrocartilage tissue regeneration within denuded articular
surface in the superficial zone, and new vessel formation
(angiogenesis) which resulted in discontinuity of chondral
zone and subchondral bone trabeculae as well as proliferation
of fibrous tissue formation that were prominent at the margin
of articular surface and also in the superficial zone. In treat-
ment group animals, normal articular cartilage was not
observed and there was a newly repaired fibrocartilaginous or
cartilage-like tissue. A moderate loss of Safranin-O staining in
right knee joint hyaline cartilage matrix was observed in
control group, while a severe loss of Safranin-O staining was
observed in treatment groups. Loss of matrix staining can be
attributed to transient endogenous proteoglycan degradation
or to proteoglycan diffusion into fixative during storage in
formalin. Histological analysis of sections of right knee joints
at lesion sites showed a significant decrease in Mankin’s score
in groups treated with HA alone or in combination with rop-
ivacaine hydrochloride and triamcinolone acetonide versus
control. This evidence was consistent with strong articular
degenerative changes in controls’ right knee joints (grade III
OA), while the treatment groups revealed less severe articular
degenerative changes (grade II OA).
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